This inventor holds 1 USPTO granted patent. Top assignee: Daewon Pharm., Co., Ltd.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Yong Bok Lee - Innovator in Antianemic Agents
Introduction
Yong Bok Lee is a notable inventor based in Kwangju, South Korea. He has made significant contributions to the field of medicine, particularly in the development of antianemic agents. His innovative approach addresses the critical issue of iron-deficiency anemia, which affects many individuals worldwide.
Latest Patents
Yong Bok Lee holds a patent for an antianemic agent containing iron and difructose. This invention is designed to treat anemia caused by iron deficiency. The antianemic agent is formulated to allow iron and difructose to form a complex, with an appropriate molar ratio ranging from 1:0.5 to 1:1000. Additionally, the agent may include hematopoietics such as cyanocobalamine, pyridoxine hydrochloride, and folic acid to enhance its effectiveness.
Career Highlights
Yong Bok Lee is associated with Daewon Pharm., Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in the creation of effective treatments for anemia.
Collaborations
Yong Bok Lee collaborates with talented colleagues, including Bu Hyun Baik and Young Woo Lee. Their combined expertise fosters a productive environment for innovation and advancement in their field.
Conclusion
Yong Bok Lee's contributions to the development of antianemic agents highlight his commitment to improving health outcomes for individuals suffering from iron deficiency. His innovative work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile